跳至主要内容
临床试验/JPRN-UMIN000037148
JPRN-UMIN000037148已完成未知

Clinical research on the effect of changing from denosumab to zoledronic acid (Multicenter collaborative retrospective observational research) - SM201901

Orthopedics Department, Shimura Hospital0 个研究点目标入组 30 人开始时间: 2019年6月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

either clinical vertebral fractures nor X-ray morphological new vertebral fractures occurred in 30 patients evaluated for fractures at 6 months and 12 months after ZOL administration.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Patients undergoing treatment for malignancy (2) Patients with severe heart disease and cerebrovascular disease (3) Patients with serious diseases such as pancreas and blood (4) Patients with severe renal dysfunction or failure (for example, patients with eGFR (estimated glomerular filtration rate) less than 3.0 mL /min/1.73 m2, patients on dialysis) (5) In addition, patients that the research investigator or the doctor judged inappropriate for the target

研究者

发起方
Orthopedics Department, Shimura Hospital

相似试验